NPS Pharmaceuticals, Inc. (NPSP) Posts Q3 Loss of 4c/Share

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) reported Q3 EPS of ($0.04), $0.12 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $27.02 million versus the consensus estimate of $28.18 million.

For earnings history and earnings-related data on NPS Pharmaceuticals, Inc. (NPSP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• Burry doubles down on Nebius short after stock surges 34% on earnings
• Parker Hannifin completes acquisition of Filtration Group Corporation